IL6 and diabetes mellitus: In a recent study, Luo et al. (2015) demonstrated that kaempferol suppressed inflammatory lesions in diabetes by reducing TNF-α and IL-6 levels along with the reduced expression of IκB kinase (IKK) and the subsequent inhibition of the NF-κB pathway activation [29].